U.S. Food and Drug Administration (FDA) Commissioner Scott Gottlieb announced on March 5 that he is resigning the position, effective in one month.
Gottlieb, who was praised in many health advocate circles, upheld Obama administration priorities like menu labeling and labeling added sugars on food packages. Within the Trump administration, he was recognized for efforts to more tightly regulate electronic cigarettes and make generic drugs more accessible.
Gottlieb is a physician who previously was FDA’s deputy commissioner for medical and scientific affairs. He became commissioner in May 2017, and said his resignation was spawned by a desire to return to his family, which did not relocate to the Washington area.
President Trump tweeted his praise for the commissioner on March 5, writing that he has done “an absolutely terrific job…Scott has helped us to lower drug prices, get a record number of generic drugs approved and onto the market, and so many other things. He and his talents will be greatly missed!”